# BugSigDB 1.0, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/4/2_adenoma:Proximal-conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/6/1_adenoma:Non-advanced-conventional-adenoma-cases_vs_controls_UP	NA	33024
bsdb:2/1/1_squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_UP	NA	543311
bsdb:2/1/2_squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_DOWN	NA	1654
bsdb:2/2/1_squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_UP	NA	543311
bsdb:2/3/1_squamous-cell-carcinoma:T3-T4-stages-patients_vs_T0-T2-stages-patients_UP	NA	543311
bsdb:3/1/1_colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_UP	NA	836
bsdb:5/1/2_chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1663
bsdb:5/2/1_chronic-obstructive-pulmonary-disease:Severe_vs_moderate-Chronic-obstructive-pulmonary-disease_UP	NA	642
bsdb:10/1/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	437755
bsdb:14/1/1_oral-halitosis:Oral-Halitosis_vs_Control_UP	NA	838
bsdb:14/1/2_oral-halitosis:Oral-Halitosis_vs_Control_DOWN	NA	838
bsdb:16/1/1_obesity:high-fat-diet_vs_normal-chow-diet_UP	NA	572511
bsdb:16/1/2_obesity:high-fat-diet_vs_normal-chow-diet_DOWN	NA	459786
bsdb:16/2/1_obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_UP	NA	1920251
bsdb:19/1/1_schizophrenia:Schizophrenia_vs_Healthy-controls_UP	NA	872
bsdb:20/1/1_non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_UP	NA	816
bsdb:20/2/1_non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_UP	NA	816
bsdb:21/1/1_obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_UP	NA	39948
bsdb:21/1/2_obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_DOWN	NA	239759
bsdb:23/1/2_alzheimer's-disease:Alzheimer's_vs_Healhty-controls_DOWN	NA	86331
bsdb:24/1/1_chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_UP	NA	1378
bsdb:24/1/2_chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	286
bsdb:25/1/1_psoriasis:Psoriasis-Male_vs_Female_UP	NA	171412
bsdb:25/1/2_psoriasis:Psoriasis-Male_vs_Female_DOWN	NA	1696
bsdb:26/2/1_obesity:BMI->33-female_vs_male_UP	NA	816
bsdb:27/1/2_obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_DOWN	NA	1331051
bsdb:27/2/2_obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_DOWN	NA	1331051
bsdb:28/1/1_chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_UP	NA	100883
bsdb:28/1/2_chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_DOWN	NA	40544
bsdb:29/1/2_unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	620
bsdb:30/1/1_chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_UP	NA	61170
bsdb:30/1/2_chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_DOWN	NA	375288
bsdb:30/2/1_chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_UP	NA	420345
bsdb:30/2/2_chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_DOWN	NA	84036
bsdb:30/3/1_chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_UP	NA	420345
bsdb:30/3/2_chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_DOWN	NA	553372
bsdb:31/2/1_chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	207244
bsdb:31/3/2_chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_DOWN	NA	189330
bsdb:32/1/2_anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_DOWN	NA	1485
bsdb:34/1/2_bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:34/2/1_bipolar-disorder:Bipolar-patients-with-high-IL-6_vs_low-IL-6_UP	NA	1301
bsdb:34/4/1_bipolar-disorder:Bipolar-patients-with-high-LDL_vs_low-LDL_DOWN	NA	838
bsdb:34/6/1_bipolar-disorder:Bipolar-patients-with-high-TBARS-level_vs_low-TBARS-level_UP	NA	1730
bsdb:34/7/1_bipolar-disorder:Bipolar-patients-with-high-MDA-level_vs_low-MDA-level_DOWN	NA	216851
bsdb:34/10/2_bipolar-disorder:Bipolar-patients-with-depressive-syndrome_vs_healthier-bipolar-patients_DOWN	NA	841
bsdb:34/11/2_bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:36/1/2_obesity:obese-adolescent_vs_control-adult_DOWN	NA	119852
bsdb:36/2/1_obesity:obese-adult_vs_contorl-adolescent_UP	NA	1301
bsdb:36/2/2_obesity:obese-adult_vs_contorl-adolescent_DOWN	NA	119852
bsdb:36/3/2_obesity:control-adolescent_vs_control-adult_DOWN	NA	1301
bsdb:37/1/2_colorectal-cancer:CRC-patients_vs_Healthy-controls_DOWN	NA	1301
bsdb:39/1/2_body-odor-measurement:youth-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/3/1_body-odor-measurement:Children-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/4/1_body-odor-measurement:Children-Neck-before_vs_after-excercise_UP	NA	1279
bsdb:39/4/2_body-odor-measurement:Children-Neck-before_vs_after-excercise_DOWN	NA	1912216
bsdb:39/5/1_body-odor-measurement:teen-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/6/1_body-odor-measurement:teen-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:40/1/2_attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	33042
bsdb:42/1/1_extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_UP	NA	158846
bsdb:42/1/2_extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_DOWN	NA	102106
bsdb:43/1/1_behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	1283313
bsdb:45/1/1_obesity:Rats-fed--HFHS_vs_control-rats_UP	NA	174708
bsdb:47/1/1_obesity:low_vs_high-dietary-fiber_UP	NA	1263
bsdb:48/1/1_obesity:obese-adolescent_vs_control-adolescent_UP	NA	838
bsdb:48/1/2_obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	459786
bsdb:48/2/1_obesity:high-BMI-zscore_vs_low-BMI-zscores_UP	NA	838
bsdb:48/2/2_obesity:high-BMI-zscore_vs_low-BMI-zscores_DOWN	NA	239759
bsdb:48/3/1_obesity:high-triglycerides_vs_low-triglycerides_UP	NA	838
bsdb:48/3/2_obesity:high-triglycerides_vs_low-triglycerides_DOWN	NA	816
bsdb:48/4/1_obesity:high-total-cholesterol_vs_low-total-cholesterol_DOWN	NA	816
bsdb:48/5/1_obesity:high-HDL-C_vs_low-HDL-C_UP	NA	816
bsdb:48/6/1_obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_UP	NA	838
bsdb:48/6/2_obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_DOWN	NA	459786
bsdb:49/1/2_obesity:Obesity-group_vs_controls_DOWN	NA	40323
bsdb:50/1/1_colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_UP	NA	1257
bsdb:50/1/2_colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_DOWN	NA	577310
bsdb:51/1/1_colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_UP	NA	1654
bsdb:51/2/1_colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_UP	NA	123375
bsdb:51/2/2_colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	244127
bsdb:52/1/1_substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_UP	NA	33057
bsdb:52/2/1_substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_UP	NA	838
bsdb:52/2/2_substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_DOWN	NA	1407607
bsdb:55/1/1_stimulus-or-stress-design:grid-floor-induced-stress_vs_control_UP	NA	239759
bsdb:56/1/1_type-II-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_UP	NA	620
bsdb:56/2/1_gestational-diabetes:Baby-meconium-with-GDM-mothers_vs_Healthy-baby-meconium_DOWN	NA	40323
bsdb:57/1/1_inflammatory-bowel-disease:irritable-bowel-syndrome_vs_control_UP	NA	482
bsdb:57/1/2_inflammatory-bowel-disease:irritable-bowel-syndrome_vs_control_DOWN	NA	286
bsdb:57/2/1_inflammatory-bowel-disease:overweight-irritabe-bowel-syndrome_vs_control_UP	NA	1279
bsdb:57/2/2_inflammatory-bowel-disease:overweight-irritabe-bowel-syndrome_vs_control_DOWN	NA	1279
bsdb:58/1/1_high-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_UP	NA	1350
bsdb:58/1/2_high-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_DOWN	NA	283
bsdb:58/2/1_high-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_UP	NA	561
bsdb:58/2/2_high-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_DOWN	NA	816
bsdb:60/1/1_type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_UP	NA	255204
bsdb:60/1/2_type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_DOWN	NA	1847
bsdb:60/2/1_type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_UP	NA	504481
bsdb:60/2/2_type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_DOWN	NA	816
bsdb:61/1/1_obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-1-month_DOWN	NA	838
bsdb:61/3/1_obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-1-month_DOWN	NA	838
bsdb:63/2/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-after-3-months-of-delivery_DOWN	NA	1578
bsdb:64/4/2_periodontitis:periodnotitis_vs_No-Periodontitis-within-positive-diabetic-background-only_DOWN	NA	482
bsdb:65/1/1_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	970
bsdb:65/1/2_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	157
bsdb:66/1/1_neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_UP	NA	106589
bsdb:66/2/2_neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	1301
bsdb:67/3/1_autism:constipated-autistic_vs_non-constipated-autistic_UP	NA	1485
bsdb:67/4/1_autism:constipated-neurotypical_vs_non-constipated-neurotypical_DOWN	NA	204475
bsdb:68/2/1_obesity:overweight_vs_normal-weight_UP	NA	35832
bsdb:68/3/2_obesity:obese-men_vs_normal-weight-men_DOWN	NA	1263
bsdb:68/4/1_obesity:overweight-men_vs_normal-weight-men_UP	NA	140625
bsdb:68/5/1_obesity:obese-women_vs_normal-weight-women_UP	NA	1263
bsdb:68/5/2_obesity:obese-women_vs_normal-weight-women_DOWN	NA	51514
bsdb:69/1/1_sex-design:female_vs_male_UP	NA	1263
bsdb:69/2/1_obesity:female-obese_vs_female-normal-weight_DOWN	NA	33024
bsdb:69/3/1_obesity:male-obese_vs_male-normal-weight_UP	NA	848
bsdb:69/4/1_obesity:obese_vs_normal-weight_UP	NA	848
bsdb:70/1/2_obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	816
bsdb:70/2/2_obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_DOWN	NA	283168
bsdb:71/1/1_cesarean-section:cesarean-premature-birth_vs_vaginally-born-controls_UP	NA	830
bsdb:71/2/2_premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_DOWN	NA	223927
bsdb:72/1/2_autism:autism_vs_typically-developing-controls_DOWN	NA	162289
bsdb:73/1/1_obesity:obese_vs_normal-weight_UP	NA	33042
bsdb:73/2/1_obesity:obese-+-metabolic-syndrome_vs_normal-weight_UP	NA	33042
bsdb:74/1/2_obesity:obese_vs_non-obese_DOWN	NA	195950
bsdb:74/3/1_obesity:high-BMI_vs_low-BMI_UP	NA	629
bsdb:74/4/2_obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_DOWN	NA	195950
bsdb:75/1/1_smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_UP	NA	482
bsdb:75/2/1_smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_UP	NA	416916
bsdb:75/2/2_smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_DOWN	NA	34104
bsdb:75/3/1_smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_UP	NA	349
bsdb:75/3/2_smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_DOWN	NA	52784
bsdb:75/4/1_smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_UP	NA	40544
bsdb:75/4/2_smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_DOWN	NA	40323
bsdb:76/1/1_type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_UP	NA	904
bsdb:76/1/2_type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_DOWN	NA	1392389
bsdb:77/1/2_bipolar-disorder:atypical-antipsychotic-users_vs_non-users_DOWN	NA	239934
bsdb:78/1/1_stimulus-or-stress-design:limited-nesting-stress_vs_controls_UP	NA	2316
bsdb:78/1/2_stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	283168
bsdb:80/1/1_type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_UP	NA	816
bsdb:80/1/2_type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_DOWN	NA	158846
bsdb:83/1/1_obesity:before-surgery_vs_after-surgery_UP	NA	40637
bsdb:83/1/2_obesity:before-surgery_vs_after-surgery_DOWN	NA	5140
bsdb:85/1/1_cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	1266
bsdb:85/2/1_cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816
bsdb:85/3/1_cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	1266
bsdb:85/4/1_cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	102106
bsdb:86/1/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-3_UP	NA	1578
bsdb:86/3/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-28_DOWN	NA	816
bsdb:86/4/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-150_DOWN	NA	816
bsdb:86/7/2_cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_DOWN	NA	239759
bsdb:87/1/1_type-I-diabetes-mellitus:Type-I-Diabetics_vs_maturity-onset-diabetes-of-the-young-2-(MODY2)-and-healthy-Controls_UP	NA	40544
bsdb:87/2/1_type-I-diabetes-mellitus:Type-I-Diabetics-and-maturity-onset-diabetes-of-the-young-2-(MODY2)_vs_healthy-Controls_DOWN	NA	216851
bsdb:88/1/1_schizophrenia:schizophrenia_vs_non-psychiatric-controls_UP	NA	572511
bsdb:89/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-in-transitional-stools_DOWN	NA	375288
bsdb:90/1/1_cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_UP	NA	209
bsdb:90/1/2_cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_DOWN	NA	80865
bsdb:90/2/1_cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_UP	NA	1350
bsdb:90/2/2_cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_DOWN	NA	165695
bsdb:91/1/2_cesarean-section:C-section-delivery_vs_vaginal-delivery_DOWN	NA	286
bsdb:93/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery_DOWN	NA	1279
bsdb:93/2/1_cesarean-section:Antimicrobials-use-during-delivery-yes_vs_no_UP	NA	1678
bsdb:93/3/1_cesarean-section:Maternal-consumption-of-probiotics-yes_vs_no_UP	NA	1578
bsdb:93/4/1_cesarean-section:Furry-pets-at-home-yes_vs_no_UP	NA	216851
bsdb:95/1/1_obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_UP	NA	841
bsdb:95/1/2_obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_DOWN	NA	375288
bsdb:97/2/1_obesity:Roux-en-Y-gastric-bypass-(RYGB)_vs_healthy-controls_UP	NA	906
bsdb:97/4/1_obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_UP	NA	216851
bsdb:98/1/2_chronic-kidney-disease:CKD_vs_controls_DOWN	NA	1506577
bsdb:99/1/2_obesity:obese_vs_controls_DOWN	NA	239759
bsdb:100/1/1_obesity:High-BMI_vs_low-BMI_UP	NA	838
bsdb:100/2/1_obesity:Abdominal-obesity_vs_non-abdominal-obesity_UP	NA	838
bsdb:100/2/2_obesity:Abdominal-obesity_vs_non-abdominal-obesity_DOWN	NA	119852
bsdb:101/1/1_obesity:obese_vs_lean-controls_UP	NA	1578
bsdb:102/1/1_type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_UP	NA	1263
bsdb:102/1/2_type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_DOWN	NA	239759
bsdb:103/1/2_unipolar-depression:depressed-female_vs_Healthy-Controls_DOWN	NA	638847
bsdb:103/2/2_unipolar-depression:depressed-male_vs_Healthy-Controls_DOWN	NA	638847
bsdb:104/1/1_unipolar-depression:major-depressive-disoreder-(visit-1)_vs_healthy-controls_UP	NA	1301
bsdb:104/2/1_unipolar-depression:major-depressive-disoreder-(visit-2)_vs_healthy-controls_UP	NA	1301
bsdb:105/1/1_unipolar-depression:bipolar_vs_healthy-controls_DOWN	NA	216851
bsdb:106/1/1_bipolar-disorder:bipolar_vs_healthy-controls_UP	NA	946234
bsdb:107/1/2_anorexia-nervosa:anorexia_vs_healthy-controls_DOWN	NA	216851
bsdb:107/2/1_anorexia-nervosa:anorexia_vs_healthy-controls_UP	NA	375288
bsdb:109/1/1_anorexia-nervosa:anorexia-patients-before-weight-gain_vs_HC_UP	NA	207244
bsdb:109/1/2_anorexia-nervosa:anorexia-patients-before-weight-gain_vs_HC_DOWN	NA	841
bsdb:109/2/1_anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_UP	NA	1357
bsdb:109/2/2_anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_DOWN	NA	816
bsdb:110/1/1_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1578
bsdb:111/1/2_attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	39948
bsdb:112/1/1_attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_UP	NA	816
bsdb:112/1/2_attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_DOWN	NA	375288
bsdb:114/1/1_unipolar-depression:MDD_vs_controls_UP	NA	1378
bsdb:114/1/2_unipolar-depression:MDD_vs_controls_DOWN	NA	189330
bsdb:116/1/1_type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_UP	NA	29465
bsdb:116/1/2_type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	1578
bsdb:117/1/1_pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	1578
bsdb:117/1/2_pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	32067
bsdb:117/2/1_pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	1578
bsdb:117/2/2_pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	482
bsdb:118/1/2_cesarean-section:cesarean-born_vs_vaginal-born-children_DOWN	NA	1678
bsdb:118/2/1_cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_UP	NA	1350
bsdb:119/1/1_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_UP	NA	1678
bsdb:119/2/1_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_UP	NA	838
bsdb:119/2/2_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_DOWN	NA	1678
bsdb:119/3/1_type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_UP	NA	1678
bsdb:119/3/2_type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_DOWN	NA	838
bsdb:120/1/1_physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_UP	NA	816
bsdb:120/2/1_physical-activity:Ad-libitum-group_vs_exercise-group_UP	NA	1485
bsdb:121/1/2_gingivitis:gingivitis_vs_healthy-controls_DOWN	NA	1016
bsdb:122/1/1_breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	407
bsdb:123/1/1_diet:high-fat-diet_vs_low-fat-diet_UP	NA	102106
bsdb:123/1/2_diet:high-fat-diet_vs_low-fat-diet_DOWN	NA	588605
bsdb:124/1/2_diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1357
bsdb:124/2/1_diet:body-builders-(high-protein)_vs_control_UP	NA	1432051
bsdb:124/2/2_diet:body-builders-(high-protein)_vs_control_DOWN	NA	1243
bsdb:124/3/1_diet:distance-runners-(high-carb)_vs_control_UP	NA	40544
bsdb:124/3/2_diet:distance-runners-(high-carb)_vs_control_DOWN	NA	1243
bsdb:125/1/1_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_UP	NA	1016
bsdb:125/1/2_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_DOWN	NA	724
bsdb:126/1/1_oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_UP	NA	1386
bsdb:126/1/2_oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_DOWN	NA	46123
bsdb:126/2/1_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_UP	NA	1386
bsdb:126/2/2_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_DOWN	NA	46123
bsdb:126/3/1_oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_UP	NA	1301
bsdb:126/3/2_oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_DOWN	NA	1386
bsdb:127/1/1_alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	61170
bsdb:127/1/2_alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	216851
bsdb:128/1/1_gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_UP	NA	1301
bsdb:128/1/2_gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_DOWN	NA	235572
bsdb:128/2/1_gastric-cancer:gastric-cancer_vs_atrophic-gastric_UP	NA	437755
bsdb:128/2/2_gastric-cancer:gastric-cancer_vs_atrophic-gastric_DOWN	NA	235572
bsdb:128/3/1_gastric-cancer:gastric-cancer_vs_superficial-gastric_UP	NA	437755
bsdb:128/3/2_gastric-cancer:gastric-cancer_vs_superficial-gastric_DOWN	NA	235572
bsdb:129/1/1_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	286
bsdb:129/1/2_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	724
bsdb:130/1/1_diet:high-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/2/1_diet:intermediate-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/5/1_diet:>-30-years-participants_vs_20-30-years-participants_UP	NA	1578
bsdb:130/6/2_diet:BMI->25_vs_BMI-<-20_DOWN	NA	1678
bsdb:130/7/1_diet:BMI-20-25_vs_BMI-<20_DOWN	NA	1678
bsdb:131/2/2_diet:Time-7-days_vs_Time-0-days-Cara-Cara_DOWN	NA	283168
bsdb:131/4/1_diet:Cara-Cara_vs_controls-at-time-7_UP	NA	574697
bsdb:131/5/1_diet:Bahia_vs_controls-at-time-7_UP	NA	244127
bsdb:132/1/1_diet:Meat_vs_mushroom_UP	NA	189330
bsdb:132/1/2_diet:Meat_vs_mushroom_DOWN	NA	40544
bsdb:134/1/1_diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	872
bsdb:134/2/1_diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	872
bsdb:135/1/1_diet:High-animal-protein_vs_low-animal-protein_UP	NA	816
bsdb:136/2/1_diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	572511
bsdb:137/1/1_colorectal-cancer:CRC_vs_controls_UP	NA	848
bsdb:137/1/2_colorectal-cancer:CRC_vs_controls_DOWN	NA	841
bsdb:138/1/2_lung-cancer:lung-cancer_vs_controls_DOWN	NA	1257
bsdb:139/3/1_squamous-cell-carcinoma:Pharynx-cancer-cases_vs_controls_DOWN	NA	32257
bsdb:139/4/1_squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_UP	NA	1654
bsdb:140/1/2_multiple-sclerosis:multiple-sclerosis_vs_controls_DOWN	NA	574697
bsdb:140/2/2_multiple-sclerosis:multiple-sclerosis_vs_controls_DOWN	NA	574697
bsdb:140/3/1_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934
bsdb:140/3/2_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	40544
bsdb:140/4/1_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934
bsdb:140/4/2_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	40544
bsdb:140/5/1_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_UP	NA	40544
bsdb:140/5/2_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_DOWN	NA	1266
bsdb:140/6/1_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_UP	NA	838
bsdb:140/6/2_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_DOWN	NA	1266
bsdb:142/1/1_squamous-cell-carcinoma:HNSCC_vs_Controls_UP	NA	29465
bsdb:142/1/2_squamous-cell-carcinoma:HNSCC_vs_Controls_DOWN	NA	32067
bsdb:142/2/1_squamous-cell-carcinoma:HPV-+_vs_HPV--_UP	NA	1013
bsdb:142/2/2_squamous-cell-carcinoma:HPV-+_vs_HPV--_DOWN	NA	32067
bsdb:142/3/1_squamous-cell-carcinoma:chemothrapy-radiation-and-surgery_vs_surgery_UP	NA	1578
bsdb:142/4/1_squamous-cell-carcinoma:chemothrapy-radiation-and-surgery_vs_surgery_DOWN	NA	32067
bsdb:144/1/1_air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_UP	NA	1654
bsdb:144/1/2_air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_DOWN	NA	475
bsdb:144/2/2_air-pollution:heavily-polluted-region-(C)_vs_lightly-poluuted-region-(A)_DOWN	NA	194
bsdb:144/3/2_air-pollution:heavily-polluted-region-(C)_vs_moderately-poluuted-region-(B)_DOWN	NA	482
bsdb:147/1/2_squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_DOWN	NA	32207
bsdb:148/1/1_polycystic-ovary-syndrome:NIR-PCOS_vs_HC_UP	NA	28050
bsdb:148/1/2_polycystic-ovary-syndrome:NIR-PCOS_vs_HC_DOWN	NA	838
bsdb:148/2/2_polycystic-ovary-syndrome:IR-PCOS_vs_HC_DOWN	NA	838
bsdb:148/3/1_polycystic-ovary-syndrome:NIR-PCOS_vs_IR-PCOS_UP	NA	816
bsdb:149/1/1_obesity:Obese_vs_controls_UP	NA	158846
bsdb:152/1/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	189330
bsdb:152/1/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	33024
bsdb:153/1/1_prostate-cancer:prostate-cancer_vs_controls_UP	NA	547
bsdb:153/1/2_prostate-cancer:prostate-cancer_vs_controls_DOWN	NA	44249
bsdb:154/1/1_colorectal-cancer:colorectal-cancer_vs_healthy-controls_UP	NA	59732
bsdb:154/1/2_colorectal-cancer:colorectal-cancer_vs_healthy-controls_DOWN	NA	613
bsdb:155/1/1_esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	970
bsdb:155/1/2_esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	724
bsdb:156/1/1_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	375288
bsdb:156/1/2_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	1506553
bsdb:156/2/2_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	1506553
bsdb:157/1/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_UP	NA	1578
bsdb:157/1/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_DOWN	NA	963
bsdb:157/2/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	816
bsdb:157/2/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	2717
bsdb:158/1/1_lung-cancer:lung-cancer_vs_healthy-volunteers_UP	NA	33024
bsdb:158/1/2_lung-cancer:lung-cancer_vs_healthy-volunteers_DOWN	NA	620
bsdb:158/2/2_lung-cancer:lung-cancer_vs_healthy-volunteers_DOWN	NA	620
bsdb:159/1/1_gingival-disease:1-month-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:159/2/1_gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:160/1/1_head-and-neck-carcinoma:OCC-&-OPC_vs_High-risk-individuals_DOWN	NA	47670
bsdb:160/2/1_head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_UP	NA	265975
bsdb:160/2/2_head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_DOWN	NA	1016
bsdb:161/1/1_lung-cancer:NSCLC_vs_healthy-controls_UP	NA	29465
bsdb:161/1/2_lung-cancer:NSCLC_vs_healthy-controls_DOWN	NA	836
bsdb:161/2/1_lung-cancer:NSCLC_vs_healthy-controls_UP	NA	47670
bsdb:163/1/1_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	970
bsdb:166/1/1_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	84111
bsdb:167/3/1_squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_UP	NA	1730
bsdb:168/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_DOWN	NA	543311
bsdb:168/3/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_UP	NA	836
bsdb:168/3/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_DOWN	NA	1654
bsdb:170/1/2_lung-cancer:cancerous-site_vs_controls_DOWN	NA	1279
bsdb:170/2/1_lung-cancer:paired-contralateral-non-cancerous-site_vs_controls_UP	NA	970
bsdb:170/4/1_lung-cancer:cacerous-site-with-no-antibiotics_vs_control-groups-with-no-antibiotics_UP	NA	1016
bsdb:171/1/1_digestive-system-cancer:digestive-track-cancers_vs_controls_UP	NA	848
bsdb:171/1/2_digestive-system-cancer:digestive-track-cancers_vs_controls_DOWN	NA	32207
bsdb:171/3/1_esophageal-cancer:esophageal-cancer_vs_controls_UP	NA	482
bsdb:172/1/1_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	86331
bsdb:172/3/1_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	32207
bsdb:172/3/2_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735
bsdb:173/1/1_pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_UP	NA	416916
bsdb:173/1/2_pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_DOWN	NA	204475
bsdb:173/2/1_pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_without-cancer_UP	NA	117563
bsdb:173/2/2_pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_without-cancer_DOWN	NA	118966
bsdb:175/1/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_UP	NA	1283313
bsdb:175/1/2_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:175/3/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:176/1/1_leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_UP	NA	1654
bsdb:177/1/2_colorectal-cancer:mucosa_vs_control_DOWN	NA	1301
bsdb:177/2/1_colorectal-cancer:tumor_vs_control_UP	NA	1257
bsdb:177/3/1_colorectal-cancer:fecal_vs_control_UP	NA	1257
bsdb:177/3/2_colorectal-cancer:fecal_vs_control_DOWN	NA	841
bsdb:178/2/1_gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_UP	NA	572511
bsdb:178/3/2_gastric-cancer:gastric-cancer-tumor-group_vs_normal_DOWN	NA	1279
bsdb:179/1/1_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	2717
bsdb:179/1/2_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	836
bsdb:179/2/1_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654
bsdb:179/2/2_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	836
bsdb:181/1/1_pancreatic-carcinoma:pancreatic-cancer_vs_controls_UP	NA	1283313
bsdb:181/1/2_pancreatic-carcinoma:pancreatic-cancer_vs_controls_DOWN	NA	32067
bsdb:184/1/1_prostate-cancer:prostate-cancer-patients_vs_controls_UP	NA	816
bsdb:184/2/1_prostate-cancer:prostate-cancer-patients_vs_controls_DOWN	NA	216851
bsdb:185/2/1_gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer_UP	NA	570
bsdb:186/1/1_prostate-cancer:prostrate-cancer_vs_non-prostrate-cancer_UP	NA	547
bsdb:186/1/2_prostate-cancer:prostrate-cancer_vs_non-prostrate-cancer_DOWN	NA	44249
bsdb:187/1/1_medroxyprogesterone-acetate:naive-(baseline-visit)_vs_depot-mdroxyprogesterone-Acetate-vaginal-microbiome-(visit-2)-among-black-participants_UP	NA	838
bsdb:187/2/1_medroxyprogesterone-acetate:white-naiive-vaginal-microbiome_vs_black-naive-vaginal-microbiome-(the-baseline-visit-)_UP	NA	150022
bsdb:187/2/2_medroxyprogesterone-acetate:white-naiive-vaginal-microbiome_vs_black-naive-vaginal-microbiome-(the-baseline-visit-)_DOWN	NA	177971
bsdb:187/3/1_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-second-visit-)_UP	NA	1578
bsdb:187/3/2_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-second-visit-)_DOWN	NA	1378
bsdb:187/4/1_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-third-visit-)_UP	NA	150022
bsdb:187/4/2_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-third-visit-)_DOWN	NA	1375
bsdb:188/1/1_cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	2701
bsdb:189/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	158846
bsdb:190/1/1_breast-milk-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk_UP	NA	13623
bsdb:190/1/2_breast-milk-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk_DOWN	NA	29465
bsdb:192/1/2_irritable-bowel-sydrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_DOWN	NA	216851
bsdb:192/2/1_irritable-bowel-sydrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_UP	NA	253238
bsdb:195/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_DOWN	NA	1016
bsdb:195/2/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_DOWN	NA	482
bsdb:196/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	375288
bsdb:197/1/1_asthma:severe-asthma_vs_non-asthma_UP	NA	1263
bsdb:197/1/2_asthma:severe-asthma_vs_non-asthma_DOWN	NA	237557
bsdb:199/1/2_ovarian-cancer:ovarian-cancer_vs_controls_DOWN	NA	2251
bsdb:200/1/2_endometrial-cancer:post_vs_pre_DOWN	NA	184869
bsdb:200/2/1_endometrial-cancer:endometrial-cancer_vs_benign_UP	NA	1578
bsdb:200/2/2_endometrial-cancer:endometrial-cancer_vs_benign_DOWN	NA	28263
bsdb:201/1/1_leukemia:induction_vs_repeat-therapy_UP	NA	459786
bsdb:201/1/2_leukemia:induction_vs_repeat-therapy_DOWN	NA	1350
bsdb:202/1/1_autism:children-with-autism-mental-regression-AMR_vs_children-with-autism-non-mental-regression-ANMR_UP	NA	1350
bsdb:204/1/1_premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-≥37-getastional-weeks_DOWN	NA	1678
bsdb:207/1/1_vulvovaginitis:BV_vs_NC_UP	NA	836
bsdb:207/1/2_vulvovaginitis:BV_vs_NC_DOWN	NA	1578
bsdb:207/2/1_vulvovaginitis:BV.VVC_vs_NC_UP	NA	838
bsdb:208/1/5_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	946234
bsdb:208/2/2_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	283
bsdb:208/4/1_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/4/2_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:209/1/1_cesarean-section:c-section-delivery_vs_vaginal-delivery_UP	NA	357
bsdb:209/1/2_cesarean-section:c-section-delivery_vs_vaginal-delivery_DOWN	NA	1301
bsdb:210/1/2_food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	29465
bsdb:210/2/2_food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	29465
bsdb:211/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	1654
bsdb:212/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	283168
bsdb:214/1/7_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	590
bsdb:215/1/1_eczema:infant-with-eczema_vs_healthy-control_UP	NA	29465
bsdb:218/1/1_hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-control_UP	NA	244127
bsdb:218/2/1_hepatocellular-carcinoma:HBV-related-HCC_vs_healthy-control_UP	NA	244127
bsdb:218/3/1_hepatocellular-carcinoma:non-HBV-non-HCV_vs_HBV-related-HCC_UP	NA	1283313
bsdb:219/3/1_diet:lower-fiber-(cracker)_vs_higher-fiber-(almonds)_DOWN	NA	40544
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	33024
bsdb:223/2/2_HIV-infection:HIV-infected-homosexual-patients_vs_healthy-controls_DOWN	NA	33024
bsdb:223/4/1_HIV-infection:homosexual_vs_hetersexual_DOWN	NA	375288
bsdb:223/5/2_HIV-infection:HAART_vs_healty-control_DOWN	NA	33024
bsdb:223/6/1_HIV-infection:HAART-untreated_vs_healthy-control_UP	NA	1578
bsdb:224/1/2_diet:barley-(WGB)_vs_baseline_DOWN	NA	283168
bsdb:224/3/2_diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_DOWN	NA	816
bsdb:226/1/2_HIV-infection:HIV-1-infected_vs_healthy-control_DOWN	NA	816
bsdb:226/2/2_HIV-infection:HIV-1-treated_vs_untreated_DOWN	NA	283168
bsdb:227/1/2_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	239934
bsdb:227/2/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301
bsdb:227/2/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1485
bsdb:227/3/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	1301
bsdb:227/3/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934
bsdb:227/4/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	100883
bsdb:227/4/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	100883
bsdb:227/5/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	160674
bsdb:229/1/1_diet:early_vs_late-pectin-incubation-time_UP	NA	816
bsdb:230/1/1_food-allergy:infant-with-food-allergy_vs_non-allergy_DOWN	NA	29465
bsdb:230/1/2_food-allergy:infant-with-food-allergy_vs_non-allergy_UP	NA	1485
bsdb:232/1/1_HIV-infection:HIV-infected-cART-negative_vs_HC_UP	NA	848
bsdb:232/1/2_HIV-infection:HIV-infected-cART-negative_vs_HC_DOWN	NA	239759
bsdb:236/1/1_diet:before-walnut-diet_vs_after-walnut-diet_UP	NA	572511
bsdb:236/1/2_diet:before-walnut-diet_vs_after-walnut-diet_DOWN	NA	1678
bsdb:236/2/1_diet:carbohydrate-replacement-(with-walnuts)_vs_replace-both_DOWN	NA	816
bsdb:236/3/1_diet:replace-both_vs_fat-replacement-(with-walnuts)_UP	NA	816
bsdb:237/1/1_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	46255
bsdb:237/1/2_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_DOWN	NA	213484
bsdb:237/2/1_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_UP	NA	1253
bsdb:237/3/1_chronic-hepatitis-C-virus-infection:hepatitis-C-patients_vs_healthy-controls_DOWN	NA	35829
bsdb:238/1/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	1301
bsdb:238/1/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	620
bsdb:238/2/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	437755
bsdb:238/2/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759
bsdb:238/3/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	437755
bsdb:238/3/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759
bsdb:239/1/1_egg-allergy:infant-with-egg-allergy_vs_healthy-control_UP	NA	1357
bsdb:239/1/2_egg-allergy:infant-with-egg-allergy_vs_healthy-control_DOWN	NA	1243
bsdb:239/2/1_egg-allergy:infant-with-egg-sensitization_vs_healthy-control_UP	NA	841
bsdb:241/1/2_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	39948
bsdb:242/1/1_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	1578
bsdb:242/1/2_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	2717
bsdb:242/2/1_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	57493
bsdb:243/1/1_gastric-cancer:current-H.pyloriI-infection_vs_non-current-H.pylori-infection_UP	NA	1378
bsdb:243/5/1_gastric-cancer:metaplasia_vs_normal_UP	NA	191303
bsdb:244/1/3_age:18-62-years_vs_2-12-years_UP	NA	165779
bsdb:244/1/4_age:18-62-years_vs_2-12-years_DOWN	NA	724
bsdb:244/2/1_atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1279
bsdb:244/2/2_atopic-eczema:lesional-skin_vs_non-lesional-skin_DOWN	NA	848
bsdb:244/3/1_age:13-62-years_vs_2-12-years_UP	NA	1578
bsdb:244/3/2_age:13-62-years_vs_2-12-years_DOWN	NA	724
bsdb:244/3/3_age:13-62-years_vs_2-12-years_UP	NA	1578
bsdb:244/3/4_age:13-62-years_vs_2-12-years_DOWN	NA	724
bsdb:245/1/1_kidney-stone:kidney-stone-group_vs_healthy-control_UP	NA	561
bsdb:245/1/2_kidney-stone:kidney-stone-group_vs_healthy-control_DOWN	NA	547
bsdb:245/2/2_kidney-stone:kidney-stone-group_vs_healthy-control_DOWN	NA	35832
bsdb:246/1/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	158846
bsdb:246/1/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	158851
bsdb:246/2/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	906
bsdb:246/3/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578
bsdb:246/4/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578
bsdb:246/5/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	189330
bsdb:246/7/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	239934
bsdb:246/7/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1654
bsdb:247/1/2_diet:placebo_vs_prebiotic-(inulin-type-fructan)_DOWN	NA	1678
bsdb:247/2/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-low-dietary-fiber_DOWN	NA	1678
bsdb:247/3/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_UP	NA	189330
bsdb:247/3/2_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_DOWN	NA	1678
bsdb:247/4/1_diet:low-dietary-fiber_vs_high-dietary-fiber_DOWN	NA	216851
bsdb:248/2/1_human-papilloma-virus-infection:HPV_vs_no-HPV_UP	NA	2701
bsdb:249/1/1_hepatitis,-alcoholic:alcoholics_vs_NAC_UP	NA	374
bsdb:249/1/2_hepatitis,-alcoholic:alcoholics_vs_NAC_DOWN	NA	642
bsdb:249/2/1_hepatitis,-alcoholic:HDC_vs_NAC_UP	NA	469
bsdb:249/3/1_hepatitis,-alcoholic:MAH_vs_NAC_UP	NA	469
bsdb:249/4/1_hepatitis,-alcoholic:SAH_vs_NAC_UP	NA	1651
bsdb:251/1/1_milk-allergic-reaction:cows-milk-allergy_vs_healthy-control_UP	NA	375288
bsdb:251/1/2_milk-allergic-reaction:cows-milk-allergy_vs_healthy-control_DOWN	NA	590
bsdb:253/1/1_asthma:asthma_vs_healthy-control_UP	NA	838
bsdb:253/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	724
bsdb:253/2/1_asthma:asthma-remission_vs_healthy-control_UP	NA	543311
bsdb:253/2/2_asthma:asthma-remission_vs_healthy-control_DOWN	NA	724
bsdb:254/1/1_kidney-stone:kidney-stone-patient_vs_healthy-control_UP	NA	239759
bsdb:254/1/2_kidney-stone:kidney-stone-patient_vs_healthy-control_DOWN	NA	162289
bsdb:255/1/2_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/2/2_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/3/2_HIV-infection:HIV+_vs_HIV-_DOWN	NA	1678
bsdb:256/10/2_gastric-cancer:peritumor-HP+_vs_peritumor-HP-_DOWN	NA	375288
bsdb:257/1/1_colorectal-cancer:colorectal-cancer_vs_healthy-control_UP	NA	239934
bsdb:260/1/2_food-allergy:allergic_vs_nonallergic_DOWN	NA	816
bsdb:262/1/1_atopic-asthma:nasal-brush_vs_bronchial-brush-specimen-type_UP	NA	475
bsdb:262/1/2_atopic-asthma:nasal-brush_vs_bronchial-brush-specimen-type_DOWN	NA	32067
bsdb:262/2/1_atopic-asthma:oral-wash_vs_bronchial-brush-specimen-type_UP	NA	32067
bsdb:262/2/2_atopic-asthma:oral-wash_vs_bronchial-brush-specimen-type_DOWN	NA	1279
bsdb:262/3/1_atopic-asthma:induced-sputum_vs_nasal-brush-specimen-type_UP	NA	32067
bsdb:262/3/2_atopic-asthma:induced-sputum_vs_nasal-brush-specimen-type_DOWN	NA	475
bsdb:262/4/1_atopic-asthma:oral-wash_vs_nasal-brush-specimen-type_UP	NA	32067
bsdb:262/4/2_atopic-asthma:oral-wash_vs_nasal-brush-specimen-type_DOWN	NA	475
bsdb:262/5/1_atopic-asthma:oral-wash_vs_induced-sputum-specimen-type_UP	NA	1654
bsdb:262/5/2_atopic-asthma:oral-wash_vs_induced-sputum-specimen-type_DOWN	NA	1279
bsdb:262/6/1_atopic-asthma:induced-sputum_vs_bronchial-brush-specimen-type_UP	NA	32067
bsdb:262/7/1_atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	724
bsdb:262/7/2_atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	1301
bsdb:263/1/1_crohn-disease:chron's-disease_vs_healthy-controls_UP	NA	1301
bsdb:263/1/2_crohn-disease:chron's-disease_vs_healthy-controls_DOWN	NA	191303
bsdb:263/2/1_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_UP	NA	1301
bsdb:263/2/2_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_DOWN	NA	44748
bsdb:263/3/1_multiple-sclerosis:multiple-sceloris_vs_healthy-controls_UP	NA	191303
bsdb:263/3/2_multiple-sclerosis:multiple-sceloris_vs_healthy-controls_DOWN	NA	292632
bsdb:263/4/1_rheumatoid-arthritis:arthiritis_vs_healthy-controls_UP	NA	1301
bsdb:263/4/2_rheumatoid-arthritis:arthiritis_vs_healthy-controls_DOWN	NA	292632
bsdb:265/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2129
bsdb:265/2/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	29465
bsdb:266/1/1_diet:healthy-vegetarian_vs_healthy-non-vegetarian_UP	NA	570
bsdb:266/1/2_diet:healthy-vegetarian_vs_healthy-non-vegetarian_DOWN	NA	239934
bsdb:267/5/2_atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline_DOWN	NA	39948
bsdb:268/1/1_cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	102106
bsdb:269/1/2_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	836
bsdb:269/1/3_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	1678
bsdb:269/1/4_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	1716
bsdb:270/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	286
bsdb:270/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	222991
bsdb:270/2/1_human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_UP	NA	216851
bsdb:271/1/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	44748
bsdb:271/2/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	1730
bsdb:271/2/2_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	216851
bsdb:272/1/1_pneumonia:S.pneumoniae-positive_vs_negative_UP	NA	1301
bsdb:272/1/2_pneumonia:S.pneumoniae-positive_vs_negative_DOWN	NA	1279
bsdb:274/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	838
bsdb:274/3/1_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	177971
bsdb:274/5/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	906
bsdb:274/5/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1678
bsdb:274/7/1_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	177971
bsdb:274/7/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	162290
bsdb:275/1/1_acute-lymphoblastic-leukemia:ALL-patient_vs_healthy-sibling-control_UP	NA	816
bsdb:275/1/2_acute-lymphoblastic-leukemia:ALL-patient_vs_healthy-sibling-control_DOWN	NA	816
bsdb:276/2/2_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	904
bsdb:276/3/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1472649
bsdb:277/1/1_crohn-disease:crohn's-disease_vs_healthy-control_DOWN	NA	830
bsdb:281/1/1_acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Fecal-bacterial-composition-in-small-intestines-of-control-mice_UP	NA	572511
bsdb:281/1/2_acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Fecal-bacterial-composition-in-small-intestines-of-control-mice_DOWN	NA	572511
bsdb:282/1/2_graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_DOWN	NA	572511
bsdb:284/1/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	59735
bsdb:284/1/2_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	836
bsdb:285/1/1_multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	33024
bsdb:285/3/2_multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_DOWN	NA	189330
bsdb:286/1/2_graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	1263
bsdb:288/1/1_phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	1578
bsdb:289/1/1_health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	841
bsdb:289/1/2_health-trait:suboptimal-health-status_vs_healthy-controls_DOWN	NA	40544
bsdb:290/1/1_oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_UP	NA	838
bsdb:290/1/2_oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_DOWN	NA	1654
bsdb:290/4/1_oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_UP	NA	1578
bsdb:290/4/2_oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_DOWN	NA	1301
bsdb:292/1/2_graft-versus-host-disease:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling_DOWN	NA	1164882
bsdb:293/1/1_human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_UP	NA	2129
bsdb:293/1/2_human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_DOWN	NA	848
bsdb:293/2/1_human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_DOWN	NA	1654
bsdb:297/1/1_human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_UP	NA	1386
bsdb:297/2/1_human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_UP	NA	12916
bsdb:297/2/2_human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_DOWN	NA	1301
bsdb:298/1/1_acute-myeloid-leukemia:stool_vs_oral_UP	NA	292632
bsdb:298/1/2_acute-myeloid-leukemia:stool_vs_oral_DOWN	NA	1301
bsdb:298/2/1_acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	1301
bsdb:298/3/1_acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	1301
bsdb:301/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808
bsdb:302/3/1_asthma:exacerbated-asthma_vs_non-exacerbated-asthma_UP	NA	2701
bsdb:302/3/2_asthma:exacerbated-asthma_vs_non-exacerbated-asthma_DOWN	NA	39948
bsdb:303/1/1_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	1350
bsdb:303/1/2_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	102106
bsdb:304/1/1_antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	1380
bsdb:307/1/1_antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_UP	NA	572511
bsdb:307/2/2_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_DOWN	NA	572511
bsdb:308/2/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	191303
bsdb:308/3/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	119852
bsdb:308/4/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578
bsdb:308/5/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	375288
bsdb:308/5/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1485
bsdb:308/6/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1578
bsdb:309/2/1_cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_UP	NA	20
bsdb:310/1/1_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	561
bsdb:310/1/2_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	1678
bsdb:311/1/1_graft-versus-host-disease:post--engraftment_vs_pre--engraftment_DOWN	NA	119852
bsdb:311/2/1_graft-versus-host-disease:post--engraftment_vs_pre--engraftment_DOWN	NA	119852
bsdb:312/2/1_antimicrobial-agent:Infants-born-by-mothers-positive-to-GBS-and-received-IAP_vs_infants-born-by-mothers-negative-to-GBS_DOWN	NA	1678
bsdb:313/1/1_non-hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_UP	NA	29465
bsdb:313/1/2_non-hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_DOWN	NA	574697
bsdb:317/2/1_antimicrobial-agent:infants-delivered-to-mothers-with_vs_without-peripartum-antibiotics-usages_UP	NA	1301
bsdb:317/2/2_antimicrobial-agent:infants-delivered-to-mothers-with_vs_without-peripartum-antibiotics-usages_DOWN	NA	1350
bsdb:318/2/1_graft-versus-host-disease:acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	1730
bsdb:320/1/2_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	1263
bsdb:320/2/2_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	841
bsdb:320/3/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_DOWN	NA	1678
bsdb:320/4/2_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_DOWN	NA	1301
bsdb:321/1/1_antimicrobial-agent:10-d-old-7-10-day-treatment-infants_vs_10-d-old-2-day-treatment-infants_DOWN	NA	816
bsdb:322/1/1_oral-mucositis:newly-diagnosis-maligancies_vs_reference_UP	NA	203697
bsdb:322/1/2_oral-mucositis:newly-diagnosis-maligancies_vs_reference_DOWN	NA	713
bsdb:322/2/1_oral-mucositis:oral-mucositis_vs_no-oral-mucositis_UP	NA	146
bsdb:322/3/1_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	1279
bsdb:322/3/2_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_DOWN	NA	203697
bsdb:322/4/1_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	338
bsdb:322/5/2_oral-mucositis:mucositis-lesions_vs_all-samples_DOWN	NA	2093
bsdb:323/1/1_necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1279
bsdb:323/2/1_necrotizing-enterocolitis:NEC_vs_non-NEC_DOWN	NA	1716
bsdb:323/3/1_necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1279
bsdb:325/1/1_psoriasis:psoriasis_vs_healthy-controls_UP	NA	102106
bsdb:325/1/2_psoriasis:psoriasis_vs_healthy-controls_DOWN	NA	577309
bsdb:326/1/1_NA:Responders_vs_Non-Responders_UP	NA	838
bsdb:327/1/1_antimicrobial-agent:infants-received-short-term(<3days)-antibiotic-treatment_vs_control(no-treatment)_UP	NA	1578
bsdb:327/1/2_antimicrobial-agent:infants-received-short-term(<3days)-antibiotic-treatment_vs_control(no-treatment)_DOWN	NA	1301
bsdb:327/2/1_antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment_vs_control(no-treatment)_UP	NA	1350
bsdb:327/2/2_antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment_vs_control(no-treatment)_DOWN	NA	1301
bsdb:328/1/1_psoriatic-arthritis:psoriatic-arthiritis_vs_healthy-controls_DOWN	NA	33042
bsdb:329/1/1_antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/1/2_antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/2/1_antimicrobial-agent:IAP-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/3/1_antimicrobial-agent:IAP-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:329/4/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/4/2_antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/5/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/6/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:330/2/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1257
bsdb:330/3/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	150022
bsdb:330/3/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724
bsdb:333/1/1_antimicrobial-agent:infants-with-(Abx)_vs_without-(non-Abx)-use-of-maternal-antimicrobial-agents-at-delivery_DOWN	NA	1678
bsdb:334/1/2_antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_DOWN	NA	1678
bsdb:336/1/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_3d-sample)_vs_Antibiotic-free-group-(AF-group_3d-sample)_UP	NA	1578
bsdb:336/1/2_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_3d-sample)_vs_Antibiotic-free-group-(AF-group_3d-sample)_DOWN	NA	1485
bsdb:336/3/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_UP	NA	816
bsdb:336/4/1_antimicrobial-agent:piperacillin-tazobactam-group-(PT-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_UP	NA	1350
bsdb:336/4/2_antimicrobial-agent:piperacillin-tazobactam-group-(PT-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_DOWN	NA	570
bsdb:337/1/1_antimicrobial-agent:3-month-old-infants-either-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1407607
bsdb:337/3/2_antimicrobial-agent:12-month-old-infants-either-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	1506553
bsdb:338/1/1_obesity:obese_vs_normal-weight_UP	NA	724
bsdb:338/1/2_obesity:obese_vs_normal-weight_DOWN	NA	39948
bsdb:340/1/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	189330
bsdb:340/1/2_obesity:obese/overweight_vs_non-overweight/non-obese-children_DOWN	NA	375288
bsdb:340/2/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	189330
bsdb:340/3/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	1301
bsdb:341/1/1_nicotine-dependence:patients-with-FD,-ID,or-CD-who-currently-smoked_vs_never-smoked_UP	NA	29465
bsdb:341/2/1_nicotine-dependence:patients-with-FD,-ID,or-CD-who-currently-smokes_vs_never-smoked_DOWN	NA	838
bsdb:342/1/1_asthma:Children-who-experienced-exacerbtion_vs_children-who-did-not-experience-more-than-one-exacerbation_DOWN	NA	724
bsdb:342/2/1_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/2/2_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/3/1_asthma:Children-with-rhinovirus-A-(RV-A)_vs_children-RV-_UP	NA	1301
bsdb:342/3/2_asthma:Children-with-rhinovirus-A-(RV-A)_vs_children-RV-_DOWN	NA	1279
bsdb:342/4/1_asthma:Younger-children_vs_older-children_DOWN	NA	475
bsdb:342/5/1_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-more-than-one-exacerbation_UP	NA	475
bsdb:342/5/2_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-more-than-one-exacerbation_DOWN	NA	1279
bsdb:342/6/1_asthma:Viral-illnesses_vs_no-viral-illnesses_UP	NA	475
bsdb:342/6/2_asthma:Viral-illnesses_vs_no-viral-illnesses_DOWN	NA	1279
bsdb:342/7/1_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/7/2_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/8/1_asthma:Children-with-rhinovirus-A-infection_vs_children-rhinovirus-negative_UP	NA	1301
bsdb:342/8/2_asthma:Children-with-rhinovirus-A-infection_vs_children-rhinovirus-negative_DOWN	NA	1279
bsdb:342/9/1_asthma:Children-with-rhinovirus-C-infection_vs_children-rhinovirus-neagtive_UP	NA	1301
bsdb:342/9/2_asthma:Children-with-rhinovirus-C-infection_vs_children-rhinovirus-neagtive_DOWN	NA	1279
bsdb:342/10/1_asthma:Respiratory-illness_vs_no-respiratory-illness_UP	NA	1301
bsdb:342/10/2_asthma:Respiratory-illness_vs_no-respiratory-illness_DOWN	NA	1279
bsdb:343/1/1_leukemia:Antileukemic_vs_Allogeneic-Hematopoeitic-Stem-Cell-Transplant_UP	NA	375288
bsdb:343/1/2_leukemia:Antileukemic_vs_Allogeneic-Hematopoeitic-Stem-Cell-Transplant_DOWN	NA	816
bsdb:344/1/2_air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_DOWN	NA	283168
bsdb:345/1/1_obesity:obese_vs_normal_UP	NA	158846
bsdb:350/1/2_obesity:obese_vs_normal-weight_DOWN	NA	33024
bsdb:351/1/1_obesity:overweight/obesity_vs_normal_UP	NA	1578
bsdb:351/1/2_obesity:overweight/obesity_vs_normal_DOWN	NA	1678
bsdb:352/2/1_NA:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:352/4/1_NA:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:354/1/2_obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	872
bsdb:356/3/2_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_DOWN	NA	244127
bsdb:356/6/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_DOWN	NA	1578
bsdb:357/1/1_air-pollution:post-smog-swabs_vs_pre-smog-swabs_UP	NA	838
bsdb:357/1/2_air-pollution:post-smog-swabs_vs_pre-smog-swabs_DOWN	NA	32067
bsdb:359/1/3_smoking-behavior:current-smoker_vs_former-smoker_UP	NA	1301
bsdb:359/1/4_smoking-behavior:current-smoker_vs_former-smoker_DOWN	NA	970
bsdb:360/1/1_air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_UP	NA	1485
bsdb:360/1/2_air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1578
bsdb:360/2/2_air-pollution:mice-exposed-to-WS_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1578
bsdb:361/2/1_air-pollution:female-mice-exposed-to-cigarette-smoke_vs_control_UP	NA	816
bsdb:361/2/2_air-pollution:female-mice-exposed-to-cigarette-smoke_vs_control_DOWN	NA	283168
bsdb:361/3/1_air-pollution:ovariectomized-female-mice-exposed-to-cigarette-smoke_vs_control_UP	NA	830
bsdb:361/4/1_air-pollution:mice-exposed-to-smoke_vs_control_UP	NA	459786
bsdb:361/4/2_air-pollution:mice-exposed-to-smoke_vs_control_DOWN	NA	239759
bsdb:363/1/1_smoking-behavior:current-smokers_vs_never-smokers_UP	NA	2093
bsdb:363/1/2_smoking-behavior:current-smokers_vs_never-smokers_DOWN	NA	1378
bsdb:365/1/1_diet:mice-exposed-to-American-Diet_vs_mice-fed-control-rodent-diet._UP	NA	1263
bsdb:365/1/2_diet:mice-exposed-to-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	816
bsdb:366/1/1_non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_UP	NA	189330
bsdb:366/1/2_non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_DOWN	NA	459786
bsdb:367/1/2_obesity:obese_vs_normal-weight_DOWN	NA	119852
bsdb:367/2/2_obesity:overweight_vs_normal-weight_DOWN	NA	119852
bsdb:368/1/2_smoking-behavior:shammah-users_vs_non-shammah-users_DOWN	NA	47
bsdb:369/1/1_obesity:obese_vs_normal-weight_UP	NA	841
bsdb:369/1/2_obesity:obese_vs_normal-weight_DOWN	NA	119852
bsdb:369/2/1_obesity:after-onset-of-obesity_vs_before-onset-of-obesity_UP	NA	40544
bsdb:369/2/2_obesity:after-onset-of-obesity_vs_before-onset-of-obesity_DOWN	NA	1263
bsdb:370/1/1_air-pollution:farmworker-exposure_vs_non-farmworker-exposure_DOWN	NA	1301
bsdb:372/1/1_air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_UP	NA	1578
bsdb:374/1/1_cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-control_UP	NA	953
bsdb:374/1/2_cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-control_DOWN	NA	497
bsdb:374/2/1_cervical-cancer:cervical-cancer-cancer_vs_normal-control_UP	NA	953
bsdb:374/2/2_cervical-cancer:cervical-cancer-cancer_vs_normal-control_DOWN	NA	1263978
bsdb:376/3/1_antimicrobial-agent:patients-that-took-Piperacilin/Tazobactam_vs_before-antibiotic-exposure_UP	NA	816
bsdb:378/1/1_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	1357
bsdb:378/1/2_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_DOWN	NA	1508657
bsdb:378/2/1_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	40323
bsdb:378/2/2_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_DOWN	NA	1505663
bsdb:379/2/2_obesity:obese_vs_non-obese_UP	NA	156454
bsdb:381/1/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_UP	NA	1350
bsdb:381/1/2_response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_DOWN	NA	292632
bsdb:381/2/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_UP	NA	1505663
bsdb:383/1/1_food-allergy:child-with-food-sensitization_vs_no-food-sensitization_DOWN	NA	1485
bsdb:383/2/1_food-allergy:child-with-food-allergy_vs_no-food-allergy_DOWN	NA	189330
bsdb:384/1/1_schizophrenia:FSCZ_vs_healthy-controls_UP	NA	29465
bsdb:384/2/1_schizophrenia:TSCZ_vs_healthy-controls_UP	NA	29465
bsdb:384/3/1_schizophrenia:TSCZ_vs_FSCZ_UP	NA	1301
bsdb:384/3/2_schizophrenia:TSCZ_vs_FSCZ_DOWN	NA	29465
bsdb:385/1/1_gastric-adenocarcinoma:gastric-adenocarcinoma-(GC)_vs_superficial-gastritis-(SG)_UP	NA	1283313
bsdb:387/1/1_antimicrobial-agent:Before-ciprofloxacin-exposure_vs_after-antibiotic-exposure_UP	NA	816
bsdb:388/1/1_oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_UP	NA	848
bsdb:388/1/2_oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_DOWN	NA	41275
bsdb:389/1/1_schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	1301
bsdb:389/1/2_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:389/2/1_schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	215579
bsdb:389/2/2_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:390/1/1_schizophrenia:acute-schizphrenia_vs_healthy-controls_UP	NA	35832
bsdb:390/1/2_schizophrenia:acute-schizphrenia_vs_healthy-controls_DOWN	NA	1774107
bsdb:390/2/1_schizophrenia:scizophrenia-during-remission_vs_healthy-controls_UP	NA	191303
bsdb:390/2/2_schizophrenia:scizophrenia-during-remission_vs_healthy-controls_DOWN	NA	1432051
bsdb:392/1/1_milk-allergic-reaction:non-IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	239759
bsdb:392/2/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	816
bsdb:392/3/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	1883
bsdb:392/4/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_UP	NA	1578
bsdb:392/4/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_DOWN	NA	39948
bsdb:393/1/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-tolerant-to-cow's-milk-protein_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-non-tolerant-to-cow's-milk-protein_UP	NA	1678
bsdb:393/2/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy_vs_healthy-control_DOWN	NA	816
bsdb:394/1/1_asthma:child-with-asthma-at-age-6_vs_healthy-control_UP	NA	838
bsdb:396/1/3_atopic-eczema:atopic-dermatitis_vs_healthy-control_UP	NA	1279
bsdb:396/1/4_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	106589
bsdb:396/2/1_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_UP	NA	838
bsdb:396/2/2_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_DOWN	NA	1279
bsdb:396/3/1_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS_vs_baseline_UP	NA	838
bsdb:396/3/2_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS_vs_baseline_DOWN	NA	1279
bsdb:398/1/1_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	1279
bsdb:399/1/1_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	29465
bsdb:399/1/2_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	1016
bsdb:399/2/1_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	620
bsdb:400/1/1_asthma:asthma_vs_healthy-control_UP	NA	1730
bsdb:400/2/1_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	447020
bsdb:401/1/1_asthma:asthma_vs_healthy-control_UP	NA	970
bsdb:401/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	543311
bsdb:401/2/2_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	437755
bsdb:402/2/1_atopic-eczema:Mothers-whose-infants-developed-IgE-associated-eczema_vs_mothers-whose-infants-remained-non-allergic_UP	NA	1301
bsdb:403/1/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/1/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	547
bsdb:403/3/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/3/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	28050
bsdb:403/5/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/5/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	194
bsdb:403/6/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	547
bsdb:403/7/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	547
bsdb:403/9/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	35832
bsdb:404/1/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	239759
bsdb:404/2/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263
bsdb:404/2/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	100883
bsdb:404/3/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	61170
bsdb:405/1/1_asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/1/2_asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_DOWN	NA	946234
bsdb:405/2/1_asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/2/2_asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_DOWN	NA	39948
bsdb:406/1/2_lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_DOWN	NA	469
bsdb:407/1/2_peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_DOWN	NA	843
bsdb:408/2/1_asthma:asthma-at-1-year_vs_healthy-controls_UP	NA	32207
bsdb:409/1/1_milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	216851
bsdb:409/1/2_milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_DOWN	NA	561
bsdb:410/1/1_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_UP	NA	194
bsdb:410/1/2_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_DOWN	NA	838
bsdb:410/2/1_NA:MSM-with-gonorrhea_vs_MSM-with-no-gonorrhea_UP	NA	838
bsdb:411/1/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	52225
bsdb:411/1/2_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_DOWN	NA	620
bsdb:411/2/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301
bsdb:412/1/1_NA:HIV-positive-MA-users_vs_HIV-positive-non-MA-users_UP	NA	34104
bsdb:412/2/1_methamphetamine-dependence:Methamphetamine-users_vs_non-users_UP	NA	86331
bsdb:412/2/2_methamphetamine-dependence:Methamphetamine-users_vs_non-users_DOWN	NA	1283313
bsdb:412/3/1_methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_UP	NA	165779
bsdb:412/3/2_methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_DOWN	NA	83770
bsdb:412/4/1_NA:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_UP	NA	34104
bsdb:412/4/2_NA:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_DOWN	NA	846
bsdb:412/5/1_NA:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_UP	NA	1485
bsdb:412/5/2_NA:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_DOWN	NA	168808
bsdb:413/1/1_obsessive-compulsive-disorder:OCD_vs_healthy-controls_DOWN	NA	207244
bsdb:414/1/1_epilepsy:before-keto-diet_vs_after-keto-diet_UP	NA	39948
bsdb:415/1/1_HIV-infection:HIV-positive-women-who-have-been-taking-ART-for-more-than-1-year_vs_Age-matched-HIV-uninfected-women_UP	NA	437755
bsdb:415/3/1_age:HIV-uninfected-women-who-are-50-years-of-age-or-older_vs_HIV-uninfected-women-who-are-less-than-35-years-of-age_UP	NA	437755
bsdb:417/1/1_NA:Women-with-diabetes_vs_Women-without-diabetes_DOWN	NA	165779
bsdb:418/1/1_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872
bsdb:418/1/2_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:418/2/1_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	872
bsdb:418/2/2_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:420/2/1_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_nonprobiotic-intervention_UP	NA	1578
bsdb:421/1/1_HIV-infection:Vertically-HIV-infected-children_vs_uninfected-siblings-or-children-born-to-HIV-infected-mothers_UP	NA	100883
bsdb:421/2/1_HIV-infection:Vertically-HIV-infected-children_vs_uninfected-siblings-or-children-born-to-HIV-infected-mothers_DOWN	NA	1357
bsdb:424/1/2_pancreatic-carcinoma:PC_vs_Healthy-control_DOWN	NA	292632
bsdb:424/3/1_pancreatic-carcinoma:BO-PC_vs_NBO-PC_DOWN	NA	572511
bsdb:426/1/1_NA:autoimmune-hepatits-cases_vs_healthy-controls_UP	NA	29465
bsdb:426/1/2_NA:autoimmune-hepatits-cases_vs_healthy-controls_DOWN	NA	375288
bsdb:432/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2093
bsdb:433/1/1_cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_UP	NA	2701
bsdb:434/1/1_human-papilloma-virus-infection:HPV-+_vs_healthy-control_UP	NA	906
bsdb:435/1/1_human-papilloma-virus-infection:HPV+-persistence_vs_HPV-_UP	NA	162289
bsdb:439/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	838
bsdb:441/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1654
bsdb:441/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	1485
bsdb:441/2/2_NA:H1N1-cases_vs_Healthy-controls_UP	NA	162289
bsdb:441/3/1_COVID-19:COVID-19-cases_vs_H1N1-cases_UP	NA	1485
bsdb:441/3/2_COVID-19:COVID-19-cases_vs_H1N1-cases_DOWN	NA	836
bsdb:443/1/2_irritable-bowel-sydrome:IBS_vs_Health-Control_DOWN	NA	1678
bsdb:443/2/1_irritable-bowel-sydrome:IBS-C_vs_Health-Control_UP	NA	29465
bsdb:443/4/2_irritable-bowel-sydrome:IBS-U_vs_Health-Control_DOWN	NA	29465
bsdb:447/2/1_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	970
bsdb:447/2/2_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	1243
bsdb:452/1/1_gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_UP	NA	1263
bsdb:452/1/2_gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_DOWN	NA	29465
bsdb:453/1/1_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	1392389
bsdb:453/1/2_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	570
bsdb:453/2/1_COVID-19:SARS-CoV-2-recovered-patients_vs_SARS-CoV-2-infected-patients_DOWN	NA	872
bsdb:453/2/2_COVID-19:SARS-CoV-2-recovered-patients_vs_SARS-CoV-2-infected-patients_UP	NA	1766253
bsdb:453/3/2_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	1263
bsdb:453/4/1_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_UP	NA	1766253
bsdb:453/4/2_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_DOWN	NA	255204
bsdb:455/1/1_NA:pregnant-women_vs_non-pregnant-women_UP	NA	157
bsdb:455/1/2_NA:pregnant-women_vs_non-pregnant-women_DOWN	NA	1301
bsdb:455/2/2_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women_DOWN	NA	117563
bsdb:455/2/3_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women_DOWN	NA	194
bsdb:456/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	40544
bsdb:456/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	46255
bsdb:458/1/1_COVID-19:COVID-19-cases_vs_Non-intubated-controls-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_UP	NA	13687
bsdb:458/1/2_COVID-19:COVID-19-cases_vs_Non-intubated-controls-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_DOWN	NA	29465
bsdb:459/1/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	397456
bsdb:462/1/1_type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	4930
bsdb:462/1/2_type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1124675
bsdb:462/2/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	148959
bsdb:462/2/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1891946
bsdb:462/3/1_diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_DOWN	NA	42658
bsdb:462/3/2_diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_UP	NA	1500560
bsdb:464/1/1_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_DOWN	NA	836
bsdb:464/1/2_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_UP	NA	195950
bsdb:464/2/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	836
bsdb:464/2/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	970
bsdb:464/3/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	841
bsdb:464/3/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	117563
bsdb:465/1/2_diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_DOWN	NA	216851
bsdb:467/1/1_NA:Her2-positive-tumor_vs_Her2-negative-tumor_UP	NA	904
bsdb:467/1/2_NA:Her2-positive-tumor_vs_Her2-negative-tumor_DOWN	NA	1263
bsdb:467/2/2_NA:later-age-at-menarche-(≥12)_vs_early-age-at-menarche-(≤11)_DOWN	NA	1263
bsdb:467/3/1_NA:ER-_vs_ER+_DOWN	NA	29465
bsdb:467/5/1_NA:Grade-High-(III)_vs_Grade-Low-(I/II)_UP	NA	84111
bsdb:467/5/2_NA:Grade-High-(III)_vs_Grade-Low-(I/II)_DOWN	NA	207244
bsdb:467/6/1_NA:Stage-High-(III)_vs_Stage-Low-(I/II)_UP	NA	724
bsdb:467/6/2_NA:Stage-High-(III)_vs_Stage-Low-(I/II)_DOWN	NA	135858
bsdb:467/7/1_age:Age-≤50_vs_Age-50+_UP	NA	1357
bsdb:467/8/1_NA:Nulliparous_vs_Parous_DOWN	NA	135858
bsdb:467/9/1_body-mass-index:BMI≥25_vs_BMI<25_UP	NA	239934
bsdb:468/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	1378
bsdb:468/2/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	168808
bsdb:468/2/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1283313
bsdb:468/3/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	397864
bsdb:468/5/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	906
bsdb:470/1/2_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	292632
bsdb:472/1/2_gestational-diabetes:Pregnant-individuals-with-gestational-diabetes_vs_Pregnant-individuals-who-are-normal-glucose-tolerance-(NGT)]_DOWN	NA	140625
bsdb:473/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	724
bsdb:476/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	102106
bsdb:477/2/1_COVID-19:Severe-COVID-19-patients-requiring-ICU_vs_COVID-19-negative-controls_UP	NA	157
bsdb:477/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	838
bsdb:478/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	2050
bsdb:478/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	46123
bsdb:478/5/1_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	184869
bsdb:478/5/2_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	29465
bsdb:479/1/1_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_DOWN	NA	34072
bsdb:479/2/1_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_DOWN	NA	34072
bsdb:479/4/1_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_DOWN	NA	338
bsdb:480/1/1_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_UP	NA	1301
bsdb:480/1/2_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_DOWN	NA	1380
bsdb:480/2/1_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_UP	NA	1678
bsdb:480/2/2_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_DOWN	NA	2050
bsdb:480/3/1_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_UP	NA	1350
bsdb:480/3/2_endometriosis:Confirmed-endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-conditions_DOWN	NA	66831
bsdb:482/2/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	375288
bsdb:485/1/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	1350
bsdb:485/1/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	84111
bsdb:487/2/1_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_DOWN	NA	33042
bsdb:487/2/2_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_UP	NA	544
bsdb:487/3/1_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_DOWN	NA	397864
bsdb:487/3/2_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_UP	NA	1505657
bsdb:488/1/1_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_UP	NA	1263
bsdb:488/1/2_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_DOWN	NA	1301
bsdb:489/1/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_DOWN	NA	570
bsdb:490/1/1_irritable-bowel-sydrome:IBS_vs_Healthy-Control_UP	NA	29465
bsdb:492/1/1_type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_DOWN	NA	191303
bsdb:492/1/2_type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_UP	NA	46255
bsdb:492/3/1_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_DOWN	NA	46255
bsdb:494/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	375288
bsdb:494/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1301
bsdb:495/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	838
bsdb:495/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	577309
bsdb:495/3/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-with-Prediabetes-(PreDM)_DOWN	NA	816
bsdb:496/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465
bsdb:496/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	841
bsdb:496/2/1_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_UP	NA	848
bsdb:496/2/2_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_DOWN	NA	118747
bsdb:499/1/1_irritable-bowel-sydrome:IBS-A_vs_Healthy-Control_DOWN	NA	195950
bsdb:499/3/1_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_DOWN	NA	195950
bsdb:500/1/2_COVID-19:COVID-19-patients_vs_Non-COVID-19-pneumonia-patients_DOWN	NA	1301
bsdb:501/1/1_endometriosis:One-(1)-Stage-III-Endometriosis-patient_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions-as-well-as-women-with-Stage-I-or-Stage-II-endometriosis_UP	NA	191303
bsdb:502/1/2_irritable-bowel-sydrome:IBS_vs_Healthy-Control_DOWN	NA	29465
bsdb:502/2/2_irritable-bowel-sydrome:IBS-C_vs_Healthy-Control_DOWN	NA	816
bsdb:502/3/2_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_DOWN	NA	816
bsdb:504/4/1_NA:TPBC-tumor-tissue_vs_TPBC-normal-tissue_UP	NA	1301
bsdb:504/5/2_race:BNH_vs_WNH_DOWN	NA	20
bsdb:504/6/1_race:BNH_vs_WNH_UP	NA	28100
bsdb:504/6/2_race:BNH_vs_WNH_DOWN	NA	1578
bsdb:507/1/1_antibiotic:Patients-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	29465
bsdb:507/2/1_antibiotic:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_UP	NA	1578
bsdb:507/2/2_antibiotic:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	841
bsdb:511/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	44259
bsdb:511/2/1_COVID-19:COVID-19-patients-(severe/critical)_vs_COVID-19-patients-(mild/moderate)_DOWN	NA	2740
bsdb:511/3/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	162289
bsdb:511/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	117563
bsdb:511/5/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	1380
bsdb:511/5/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	482
bsdb:512/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls-and-healthcare-workers_UP	NA	475
bsdb:513/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	29465
bsdb:513/2/1_COVID-19:COVID-19-positive-patients-with-breathing-assistance_vs_COVID-19-positive-patients-without-breathing-assistance_UP	NA	613
bsdb:514/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions_UP	NA	1301
bsdb:519/1/1_endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	816
bsdb:520/1/1_endometriosis:Stage-3/4-Endometriosis-patients_vs_Stage-1/2-Endometriosis-patients_UP	NA	165779
bsdb:521/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_DOWN	NA	1654
bsdb:521/1/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_UP	NA	212791
bsdb:522/4/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	1485
bsdb:523/1/1_endometriosis:Endo-mice_vs_Non-endo-mice_DOWN	NA	207244
bsdb:523/1/2_endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	375288
bsdb:524/1/2_NA:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_DOWN	NA	1505652
bsdb:524/2/1_NA:Individuals-diagnosed-with-Nonalcoholic-steatohepatitis-(NASH)-with-cirrhosis_vs_Healthy-controls_UP	NA	1506553
bsdb:525/1/1_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	1578
bsdb:527/1/1_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_DOWN	NA	191303
bsdb:527/1/2_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	375288
bsdb:527/2/2_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	119852
bsdb:529/2/1_arthritis:rheumatoid-arthritis_vs_Osteoarthritis_UP	NA	482
bsdb:529/2/2_arthritis:rheumatoid-arthritis_vs_Osteoarthritis_DOWN	NA	46123
